Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Freitag

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Nature Communications|August 21, 2023
Environmental and genetic predictors of human cardiovascular ageingMit Shah, Marco H de A Inácio, Chang Lu, et al.
Wellcome Open Research|March 2, 2021
Mendelian randomization for studying the effects of perturbing drug targetsDipender Gill, Marios K Georgakis, Venexia M Walker, et al.
Plos Genetics|April 18, 2013
Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseasesRicardo C Ferreira, Daniel F Freitag, Antony J Cutler, et al.
Circulation. Genomic and Precision Medicine|January 19, 2019
Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth RatesEllie Paige, Marc Clément, Fabien Lareyre, et al.
Journal of Anxiety Disorders|February 11, 2023
The Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric and parent-proxy short forms for anxiety: Psychometric properties in the Kids FACE FEARS sampleGabrielle F Freitag, Hanan Salem, Kristina Conroy, et al.
JAMA Cardiology|June 22, 2018
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization AnalysisStephen Burgess, Brian A Ference, James R Staley, et al.
The American Journal of Psychiatry|June 18, 2026
Contextualizing the Future <i>DSM</i>: Cross-Cultural, Developmental, and Multi-Informant ConsiderationsReut Naim, Pascal-M Aggensteiner, Tobias Banaschewski, et al.
European Journal of Preventive Cardiology|December 13, 2016
Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering allelesJohn M Gregson, Daniel F Freitag, Praveen Surendran, et al.
Nature Genetics|May 23, 2017
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanismsJoanna M M Howson, Wei Zhao, Daniel R Barnes, et al.
JAMA|July 8, 2015
Association of Cardiometabolic Multimorbidity With Mortality, Emanuele Di Angelantonio, Stephen Kaptoge, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Nature Communications|August 21, 2023
Environmental and genetic predictors of human cardiovascular ageingMit Shah, Marco H de A Inácio, Chang Lu, et al.
Wellcome Open Research|March 2, 2021
Mendelian randomization for studying the effects of perturbing drug targetsDipender Gill, Marios K Georgakis, Venexia M Walker, et al.
Plos Genetics|April 18, 2013
Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseasesRicardo C Ferreira, Daniel F Freitag, Antony J Cutler, et al.
Circulation. Genomic and Precision Medicine|January 19, 2019
Interleukin-6 Receptor Signaling and Abdominal Aortic Aneurysm Growth RatesEllie Paige, Marc Clément, Fabien Lareyre, et al.
Journal of Anxiety Disorders|February 11, 2023
The Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric and parent-proxy short forms for anxiety: Psychometric properties in the Kids FACE FEARS sampleGabrielle F Freitag, Hanan Salem, Kristina Conroy, et al.
JAMA Cardiology|June 22, 2018
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization AnalysisStephen Burgess, Brian A Ference, James R Staley, et al.
The American Journal of Psychiatry|June 18, 2026
Contextualizing the Future <i>DSM</i>: Cross-Cultural, Developmental, and Multi-Informant ConsiderationsReut Naim, Pascal-M Aggensteiner, Tobias Banaschewski, et al.
European Journal of Preventive Cardiology|December 13, 2016
Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering allelesJohn M Gregson, Daniel F Freitag, Praveen Surendran, et al.
Nature Genetics|May 23, 2017
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanismsJoanna M M Howson, Wei Zhao, Daniel R Barnes, et al.
JAMA|July 8, 2015
Association of Cardiometabolic Multimorbidity With Mortality, Emanuele Di Angelantonio, Stephen Kaptoge, et al.
Pageof 9